Avalon GloboCare Corp.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | — | $1.3M | $1.3M | $1.2M | $1.4M |
| Gross profit | — | — | — | $272,728 | $414,518 |
| Research and development | — | $0 | $109,618 | $731,328 | $1.0M |
| Operating expenses | — | $1.1M | $1.0M | $929,441 | $9.2M |
| Operating income | -$7.6M | -$4.8M | -$15.8M | -$8.8M | -$8.8M |
| Interest expense | $1.5M | $1.7M | $1.4M | $176,000 | — |
| Pretax income | $18.3M | $7.9M | $16.7M | -$11.9M | -$9.1M |
| Net income | -$18.3M | -$7.9M | -$16.7M | -$11.9M | -$9.1M |
| Balance Sheet | |||||
| Cash and equivalents | $109,091 | $2.7M | $285,400 | $2.0M | $807,538 |
| Current assets | $1.5M | $3.2M | $850,867 | $2.4M | $1.3M |
| Total assets | $23.4M | $21.0M | $20.6M | $19.8M | $10.2M |
| Current liabilities | $14.1M | $13.9M | $6.8M | $3.6M | $4.4M |
| Total liabilities | $14.2M | $13.9M | $13.2M | $8.6M | $7.2M |
| Stockholders' equity | $9.2M | $7.1M | $7.4M | $11.2M | $3.1M |
| Cash Flow Statement | |||||
| Cash from operations | -$4.6M | -$5.0M | -$6.5M | -$7.0M | -$5.0M |
| Depreciation and amortization | $94,443 | $611 | $211,720 | $330,723 | $311,761 |
| Stock-based compensation | $1.8M | $521,509 | $1.2M | $1.1M | $2.1M |
| Capital expenditure | — | — | $22,159 | $1,749 | $17,502 |
| Free cash flow | — | — | -$6.5M | -$7.0M | -$5.0M |
| Impairments | — | $111,033 | $454,679 | $22,285 | — |
Shares outstanding 12.0M · Free float 78.9%
Annual filing data through FY ended December 31, 2025; float as of July 14, 2026.